Comparative analysis of Parkinson’s and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion
Abstract Epidemiological studies reveal that inflammatory bowel disease (IBD) is associated with an increased risk of Parkinson’s disease (PD). Gut dysbiosis has been documented in both PD and IBD, however it is currently unknown whether gut dysbiosis underlies the epidemiological association betwee...
Saved in:
| Main Authors: | Maeve E. Krueger, Jake Sondag Boles, Zachary D. Simon, Stephan D. Alvarez, Nikolaus R. McFarland, Michael S. Okun, Ellen M. Zimmermann, Christopher E. Forsmark, Malú Gámez Tansey |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | npj Parkinson's Disease |
| Online Access: | https://doi.org/10.1038/s41531-025-00894-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peripheral blood immune cells from individuals with Parkinson's disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs
by: MacKenzie L. Bolen, et al.
Published: (2025-04-01) -
Peripheral immune cell response to stimulation stratifies Parkinson’s disease progression from prodromal to clinical stages
by: Julian R. Mark, et al.
Published: (2025-05-01) -
Sodium butyrate in Irritable Bowel Syndrome
by: Aleksandra Kołodziej, et al.
Published: (2025-06-01) -
Immune cell metabolic dysfunction in Parkinson’s disease
by: Julian R. Mark, et al.
Published: (2025-03-01) -
Sodium Butyrate in The Treatment of Irritable Bowel Syndrome KG
by: Karolina Grabowska, et al.
Published: (2025-04-01)